SCHEMBL14728689

SCHEMBL14728689

CC1(CO)CCN(c2c(Cc3ccccc3)cc(C(N)=O)c3nc4ccccc4n23)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.51
VNN1 O95497 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 6/20 0.35
ALDH1A1 P00352 5/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 1/20 0.35
KIT P10721 1/20 0.35
TSHR P16473 3/20 0.34
MAPK1 P28482 2/20 0.34
CASP1 P29466 3/20 0.34
CASP7 P55210 3/20 0.34
PKM P14618 1/20 0.34
HTT P42858 1/20 0.34
HPGD P15428 3/20 0.34
HSD17B10 Q99714 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14728692 0.92 PDE4B (0.52) PDE4BVNN1SMN1; SMN2KDM4EALDH1A1
SCHEMBL14728702 0.84 PDE4B (0.50) PDE4BSMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL14728697 0.84 PDE4B (0.54) PDE4BSMN1; SMN2KDM4EALDH1A1GAA
SCHEMBL14728704 0.84 PDE4B (0.50) PDE4BSMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL14728726 0.83 PDE4B (0.51) PDE4BSMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL14728680 0.83 KDM4E (0.44) PDE4BKDM4EALDH1A1MEN1KMT2A
SCHEMBL14728707 0.82 PDE4B (0.49) PDE4BVNN1SMN1; SMN2KDM4EALDH1A1
SCHEMBL14728671 0.81 PDE4B (0.56) PDE4BVNN1KDM4EALDH1A1MEN1
SCHEMBL14728273 0.77 PDE4B (0.80) PDE4BVNN1SMN1; SMN2KDM4EALDH1A1
SCHEMBL14716461 0.77 PDE4B (0.64) PDE4BVNN1KDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822688-B2 Imidazo[1,2-a]pyridine derivative ASTELLAS PHARMA INC. (JP) 2014-09-02 US disclosed
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE PDE4B, PDE4A, PDE4C PDE4B 1/4885VNN1 3847/4885SMN1; SMN2 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.